Clinical Trials Browser

Phase 2 × Not yet recruiting × gilteritinib × Clear all

NCT06667973 2025-03-12

Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia

Phase 2 Not yet recruiting

Other hematologic neoplasm

Disease, Leukemia, Myeloid, Acute